Hydrochlorothiazide Recalled by Unichem Pharmaceuticals
Unichem Pharmaceuticals is issuing a voluntary recall for one lot of Hydrochlorothiazide Tablets 25 mg 1000-count bottle.
The decision to recall was made as a precautionary measure after the discovery of a Clopidogrel tablet in a bottle of the product. The risk associated with mistakenly taking a Clopidogrel tablet instead of a Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel's side effects which include bleeding and/or bruising. Additionally, missing a dose of Hydrochlorothiazide could result in uncontrolled blood pressure or swelling caused by excess fluid.
The two pills are very similar in appearance. Both are light orange and circular, but Hydrochlorothiazide is scored with a "U" and a "128" on one side, while Clopidogrel is unmarked.
The affected Hydrochlorothiazide tablets include Lot # GHYL15028 - Expiration April, 2018, and was distributed nationwide directly to wholesalers, retailers, and pharmacies from May 21, 2015 to May 28, 2015.
Unichem is notifying its distributors and customers by letter, overnight FedEx and emails. Unichem is also arranging for return of all recalled products. Consumers should not consume any tablet from the affected lots.
The investigation stemmed from a solitary report from one pharmacy. No adverse events have been reported as of yet.
Consumers with questions can contact the company at (866) 931-0704.